Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation

Abstract Background An oral single dose of flecainide is used worldwide for conversion of recent onset atrial fibrillation (AF) in hemodynamically stable patients without structural heart disease. Vernakalant is a novel, rapid drug, which is used intravenously, with proven effectiveness and safety c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cardiology 2013-10, Vol.168 (3), p.2423-2425
Hauptverfasser:	Conde, Diego, Costabel, Juan Pablo, Caro, Milagros, Ferro, Alejandra, Lambardi, Florencia, Corrales Barboza, Andrea, Cobo, Augusto Lavalle, Trivi, Marcelo
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anisoles - therapeutic use Anti-Arrhythmia Agents - therapeutic use Antiarythmic agents Atrial fibrillation Atrial Fibrillation - drug therapy Biological and medical sciences Cardiac dysrhythmias Cardiology. Vascular system Cardiovascular Cardiovascular system Female Flecainide Flecainide - therapeutic use Heart Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Prospective Studies Pyrrolidines - therapeutic use Time Factors Vernakalant
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!